GE to expand in fast-growing Life Sciences sectors; extends bioprocessing manufacturing footprint in Asia, the Americas and Europe
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses
Supports the development of technologies for research and manufacture of innovative new medicines
Solutions will help more than 12,000 health care professionals attest for Meaningful Use
BARRINGTON, IL: December 9, 2013 --- GE Healthcare today announced that Centricity Practice Solution 12.0 and Centricity EMR 9.8 have been certified as solutions that eligible healthcare professionals can use to attest for the Meaningful Use 2014 measures.
Analysis of Multiplexed Proteins at Single-Cell Level Provides a Deeper Understanding of Cancer
ALISO VIEJO, CA, December 9, 2013 -- GE Healthcare today announced results from two studies that show how using the MultiOmyx™ Hodgkin Lymphoma (HL) Profile and an investigational profile for breast cancer may improve assessment of the two diseases in subsets of patients.
CHICAGO -- December 4, 2013 -- As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting.
CARDIFF, UK -- 4 December 2013 -- Dr. Nina Moran from GE Healthcare Life Sciences will be swapping a lab coat for legislation, when she visits Mr. Roger Williams MP for Brecon and Radnorshire, at the House of Commons for a "Week in Westminster" as part of a unique 'pairing' scheme run by the Royal Society -- the UK's national academy of science.
Breakthrough software innovation delivers improved clinical capabilities, personalization, lower costs and operational results
CHICAGO -- December 3, 2013 -- Today at the 2013 Radiological Society of North America (RSNA) annual meeting, GE Healthcare, a unit of General Electric Company (NYSE: GE), unveiled four software breakthroughs to deliver improved clinical capabilities, productivity and diagnostic confidence for clinicians.
CHICAGO -- December 2, 2013 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), is dedicated to providing clinicians worldwide with leading radiation dose management innovations. X-ray dose is a critical issue and GE Healthcare has collaborated with top institutions to develop strategies to better manage it. At this year's 2013 Radiological Society of North America (#RSNA13) annual meeting, GE Healthcare is showcasing several new offerings to enable low-dose imaging procedures and help clinicians track and measure dose.
